Cellectis SA

  • Biotech or pharma, therapeutic R&D
Cellectis is a biopharmaceutical company focused on gene editing and on the development of cancer immunotherapies based on allogeneic CAR T-cells (UCART).

Address

New York
United States

Website

http://www.cellectis.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS